At the end of the latest market close, ZIVO Bioscience Inc. (ZIVO) was valued at $3.78. In that particular session, Stock kicked-off at the price of $3.74 while reaching the peak value of $4.48 and lowest value recorded on the day was $3.63. The stock current value is $4.48.Recently in News on October 6, 2021, Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT. Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, medicinal and nutritional product candidates originally derived from proprietary algal cultures, announced today that Company CEO Andrew A. Dahl has been invited to present at the Global AgTech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on October 14, 2021 at 10 a.m. EDT. You can read further details here
ZIVO Bioscience Inc. had a pretty Dodgy run when it comes to the market performance.
ZIVO Bioscience Inc. (ZIVO) full year performance was -62.03%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ZIVO Bioscience Inc. shares are logging -68.89% during the 52-week period from high price, and 64.71% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.72 and $14.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1296407 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ZIVO Bioscience Inc. (ZIVO) recorded performance in the market was -62.67%, having the revenues showcasing 4.19% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 42.20M, as it employees total of 8 workers.
Analysts verdict on ZIVO Bioscience Inc. (ZIVO)
During the last month, 0 analysts gave the ZIVO Bioscience Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ZIVO is recording 0.05 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
ZIVO Bioscience Inc. (ZIVO): Technical Analysis
Raw Stochastic average of ZIVO Bioscience Inc. in the period of last 50 days is set at 33.98%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 32.94%. In the last 20 days, the company’s Stochastic %K was 22.81% and its Stochastic %D was recorded 19.22%.
Let’s take a glance in the erstwhile performances of ZIVO Bioscience Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -62.67%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -53.93%, alongside a downfall of -62.03% for the period of the last 12 months. The shares increased approximately by 19.15% in the 7-day charts and went down by 29.86% in the period of the last 30 days. Common stock shares were driven by 4.19% during last recorded quarter.